Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan

Erectile dysfunction (ED) is a prevalent form of male sexual dysfunction. Phosphodiesterase type 5 (PDE5) inhibitor is the first-line treatment for ED. Numerous well-designed and -conducted clinical trials and postmarketing studies have established the safety and efficacy of PDE5 inhibitors for the...

書誌詳細
出版年:	Urological Science
第一著者:	Bang-Ping Jiann
フォーマット:	論文
言語:	英語
出版事項:	Wolters Kluwer Health/LWW 2016-06-01
主題:	erectile dysfunction PDE5 inhibitor sildenafil tadalafil vardenafil
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S187952261630029X

類似資料

Membrane-Mediated Action of Phosphodiesterase 5 Inhibitors
著者:: Anna I. Malykhina, 等
出版事項: (2025-04-01)

Counterfeiting honey with phosphodiesterase inhibitors for sexual activity enhancement: detection using high-performance liquid chromatography coupled with a photodiode array detector (HPLC-PAD)
著者:: Abdullah M. Alkhalaf, 等
出版事項: (2024-04-01)

Phosphodiesterase Type 5 Inhibitors Greatly Affect Physicochemical Properties of Model Lipid Membranes
著者:: Anastasiia A. Zakharova, 等
出版事項: (2021-11-01)

Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review
著者:: Arman Shafiee, 等
出版事項: (2023-05-01)

The choice of the medicine phosphodiesterase inhibitors of 5th type for treating patients with erectile dysfunction and chronic prostatitis
著者:: P. V. Glybochko, 等
出版事項: (2013-06-01)

Phosphodiesterase type 5 inhibitors and erectile dysfunction
著者:: Catherine Whittaker
出版事項: (2010-06-01)

Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction
著者:: Safar Israilovich Gamidov, 等
出版事項: (2009-10-01)

Adherence to Phosphodiesterase Type 5 Inhibitors in the Treatment of Erectile Dysfunction in Long-Term Users: How Do Men Use the Inhibitors?
著者:: Ana Carvalheira, PhD, 等
出版事項: (2014-06-01)

Efficacy and Safety of Phosphodiesterase-5 Inhibitors for Erectile Dysfunction in Schizophrenia: A Systematic Review and Meta-Analysis
著者:: Saito A, 等
出版事項: (2025-09-01)

An analysis of treatment preferences and sexual quality of life outcomes in female partners of Chinese men with erectile dysfunction
著者:: Hong-Jun Li, 等
出版事項: (2016-01-01)

The INTIMA: development and validation of a new psychometric tool for the evaluation of perceived ‘Viagra Jealousy’ in erectile dysfunction therapy
著者:: Daniele Mollaioli, 等
出版事項: (2025-12-01)

Investigation of Cnidium monnieri compounds as phosphodiesterase-5 antagonists in erectile dysfunction via molecular docking and dynamic simulation
著者:: Damilola Alex Omoboyowa
出版事項: (2024-01-01)

REVITALISE: A Large Observational Study Assessing the Safety and Effectiveness of Vardenafil in Men With Erectile Dysfunction and Metabolic Syndrome
著者:: Ridwan Shabsigh, MD, FACS, 等
出版事項: (2016-09-01)

The safety and efficacy of phosphodiesterase type 5 inhibitors in the treatment of diabetic erectile dysfunction: a systematic review and meta-analysis
著者:: Zexin Zhu, 等
出版事項: (2025-10-01)

Phosphodiesterase-5 inhibitors: Raynaud's and beyond
著者:: Sanat Phatak, 等
出版事項: (2017-01-01)

Sildenafil Citrate Oral Suspension for Managing Erectile Dysfunction: A Systematic Review and a Consensus Report from the Italian Society of Andrology (SIA)
著者:: Carlos Miacola, 等
出版事項: (2024-08-01)

MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS
著者:: G. G. Sharvadze, 等
出版事項: (2018-06-01)

Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment of Erectile Dysfunction
著者:: Soad A. Mohamed, 等
出版事項: (2023-07-01)

Effect of long and short half-life PDE5 inhibitors on HbA1c levels: a systematic review and meta-analysisResearch in context
著者:: Joseph Kim, 等
出版事項: (2025-02-01)

The current treatment of erectile dysfunction
著者:: Maria Isabela Sarbu, 等
出版事項: (2016-10-01)

Effect of Tadalafil on Penile Duplex parameters in Erectile Dysfunction Patients
著者:: Ali Mohamed Younis, 等
出版事項: (2023-07-01)

Erectile Dysfunction Drugs as Potential Therapy for Cognitive Decline: Preclinical and Translational Evidence
著者:: Roberta Ricciarelli
出版事項: (2025-09-01)

PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
著者:: M. N. Mamedov, 等
出版事項: (2016-01-01)

Predictive value of systemic inflammatory response index in patients with erectile dysfunction on tadalafil unresponsive patients
著者:: Resul Sobay
出版事項: (2025-12-01)

Evidence for benefits and risks of tadalafil as a non-prescription medicine: review and evaluation using the Group Delphi technique to achieve consensus amongst clinical experts
著者:: Kurt Miller, 等
出版事項: (2023-10-01)

ERECTILE DYSFUNCTION TREATMENT USING SUBCUTANEOUS IMPLANTS WITH A LONG-TERM EFFECT
著者:: Mykola I. Boiko, 等
出版事項: (2023-12-01)

Prescription Trends and the Role of Cardiologists in the Diagnosis and Treatment of Erectile Dysfunction
著者:: Filip Tkaczyk, 等
出版事項: (2025-10-01)

Erectile dysfunction as a manifestation of urogenital autonomic neuropathy in patients with type 1 diabetes: epidemiology, classification, pathophysiology, diagnosis and treatment options
著者:: Gagik Radikovich Galstyan, 等
出版事項: (2014-07-01)

Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis
著者:: Ying Liu, 等
出版事項: (2024-08-01)

Comprehensive management of erectile dysfunction in diabetes mellitus: pathogenesis, treatment modalities, and future perspectives
著者:: Olgierd Dróżdż, 等
出版事項: (2024-08-01)

Erectile dysfunction: current situation
著者:: N. D. Akhvlediani, 等
出版事項: (2015-12-01)

Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals
著者:: Maher S Moazin, 等
出版事項: (2024-05-01)

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
著者:: Agustin R. Garcia, 等
出版事項: (2023-09-01)

The efficacy and safety of tadalafil in the management of erectile dysfunction with diabetes and blood circulation issues
著者:: Jong Seung Lee, 等
出版事項: (2023-12-01)

Effect of sildenafil on NLRP3/caspase-1 pathway in the aorta vascular tissue of rat models with erectile dysfunction
著者:: ZHANG Xijia, ZHU Bingbing, YANG Chengxia, NIU Lipan, LIU Fengxia
出版事項: (2023-11-01)

Tadalafil Once a Day for Men with Erectile Dysfunction: Is It Superior than On-Demand Administration?
著者:: Dimas Tri Prasetyo, 等
出版事項: (2019-11-01)

Tadalafil Once a Day for Men with Erectile Dysfunction: Is It Superior than On-Demand Administration?
著者:: Dimas Tri Prasetyo, 等
出版事項: (2019-11-01)

Causal effects of hypertension on risk of erectile dysfunction: A two-sample Mendelian randomization study
著者:: Zheng Wang, 等
出版事項: (2023-03-01)

Phosphodiesterase-5 inhibitors for erectile function rehabilitation in patients undergoing nerve sparing radical prostatectomy: a scoping review
著者:: GABRIEL CARVALHO ANDRADE GADELHA, 等
出版事項: (2024-11-01)

Comparison of PDE-5 inhibitors used in erectile dysfunction with some candidate molecules: A study involving molecular docking, ADMET, DFT, biological target, and activity
著者:: Süleyman Sağır, 等
出版事項: (2025-03-01)